APA (7th ed.) Citation

Gallacher, J., Taha, Y., Filipe, A. d. S., Ijaz, S., & McPherson, S. (2023). Ledipasvir/sofosbuvir and ribavirin for the treatment of ribavirin-refractory persistent hepatitis E virus infection. Elsevier.

Chicago Style (17th ed.) Citation

Gallacher, Jennifer, Yusri Taha, Ana da Silva Filipe, Samreen Ijaz, and Stuart McPherson. Ledipasvir/sofosbuvir and Ribavirin for the Treatment of Ribavirin-refractory Persistent Hepatitis E Virus Infection. Elsevier, 2023.

MLA (9th ed.) Citation

Gallacher, Jennifer, et al. Ledipasvir/sofosbuvir and Ribavirin for the Treatment of Ribavirin-refractory Persistent Hepatitis E Virus Infection. Elsevier, 2023.